A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955
Clinical trial NCT05206604 · COMPLETED
Trial details
- NCT number
- NCT05206604
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2022-08-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.